U.S. Capital Markets Stock News

NasdaqCM:REAX
NasdaqCM:REAXReal Estate

3 Stocks to Watch as Investors Look Beyond Tech for More Stable Growth

With tech stocks under pressure and expectations running high this earnings season, some investors are looking more closely at areas of the market that can sometimes feel steadier when sentiment turns cautious. This defensive sectors screener focuses on consumer staples, health care, and real estate companies that meet certain size and quality criteria, and are directly exposed to the latest news around earnings surprises, guidance resets, and interest rate expectations. In this article, you...
NYSE:CURB
NYSE:CURBRetail REITs

Does Upgraded Momentum And Earnings Outlook Change The Bull Case For Curbline Properties (CURB)?

Recently, Curbline Properties (CURB) received a Momentum Style Score of B and a Zacks Rank of #2, supported by analysts raising earnings estimates for the current and next fiscal years. This combination of upgraded projections and momentum ratings points to strengthening analyst confidence in Curbline’s operating trajectory relative to its retail REIT peers. Next, we’ll examine how these earnings estimate revisions could influence Curbline’s acquisition-led growth narrative and expectations...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

H2O America (HTO) Stock Looks Fully Priced On Its 35% One Year Run

H2O America stock has delivered a 34.6% return over the past year, yet the valuation checks currently point to the shares trading at a premium rather than offering clear value. Over the last 12 months, H2O America has returned 34.6%. This puts recent share price enthusiasm in focus against what the fundamentals suggest investors are paying. The long term investment case can be supported if H2O America continues to convert earnings into reliable dividends, while any pressure on cash flows or...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

ePlus (PLUS) Stock Could Be 15% Overvalued As Q1 Beats Land

After roughly doubling over the past five years, ePlus stock now sits at a level where the Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares trade at a premium. Broader valuation checks point to a more mixed picture rather than a clear warning sign. ePlus has returned about 102% over the past five years, so the stock is no longer an obvious bargain based purely on its recent track record. Strong recent momentum in the IT distribution and solutions business can support...
NYSE:AIN
NYSE:AINMachinery

Albany International (AIN) Partnership Puts Its Aerospace Narrative And Valuation In Focus

Albany International partnership with A&P Technology: why it matters for investors Albany International (AIN) is in focus after its Albany Engineered Composites segment agreed with A&P Technology to develop braided composite manufacturing solutions for aerospace and defense, targeting current and next generation aircraft platforms. See our latest analysis for Albany International. The new aerospace and defense partnership comes as Albany International’s share price, now at $74.54, shows...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Hub Group (HUBG) Is Up 10.9% After Freight Data Improve Amid Accounting Lawsuits Has The Bull Case Changed?

In recent days, Hub Group has drawn attention as transportation and logistics stocks rallied alongside improving freight indicators such as the Cass Freight Shipments Index, even as the company faces multiple securities class actions over alleged accounting misstatements and internal control weaknesses. This combination of stronger industry freight data and legal scrutiny over a disclosed US$77 million accounting error presents investors with a complex mix of improving sector sentiment and...
NYSE:RNR
NYSE:RNRInsurance

RenaissanceRe (RNR) Stock Still Looks Cheap As Catastrophe Risks Loom

RenaissanceRe Holdings stock has delivered a 124.7% return over the past 5 years, and the current valuation checks indicate that the shares may still be inexpensive relative to the company’s fundamentals. RenaissanceRe Holdings' 124.7% 5-year return indicates that long-term holders have already seen solid gains, so any further upside may depend on whether current expectations for the business remain intact. For a reinsurer like RenaissanceRe Holdings, the outlook for underwriting...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

How Investors Are Reacting To Take-Two Interactive Software (TTWO) Spotlighting Grand Theft Auto VI Over Earnings

Earlier this week, Jefferies analysts said Take-Two Interactive’s upcoming fiscal first-quarter update is expected to be broadly in line, but investors are primarily watching for any management commentary on the timing and scope of Grand Theft Auto VI. The key insight is that expectations and uncertainty around GTA VI, especially its online component, are now more influential for sentiment than near-term quarterly performance. We’ll now examine how this heightened focus on GTA VI’s launch...
NYSE:TX
NYSE:TXMetals and Mining

US Domestic Manufacturing Stocks Worth Watching After New Brazil Tariffs

The new 25% US tariff on a broad range of Brazilian imports puts fresh attention on US Domestic Manufacturing stocks that could see shifts in demand, costs, or competitive positioning as supply chains adjust. With key Brazilian exports like coffee, beef, orange juice, and aircraft parts exempt, the impact is focused on other areas where domestic producers might gain or face new pressures. This article walks through 3 stocks from the US Domestic Manufacturing screener that appear positively...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

Immunome (IMNM) NDA Acceptance Puts Valuation Back In Focus

Immunome (IMNM) is in focus after the FDA accepted its New Drug Application for varegacestat, an oral therapy for adults with desmoid tumors, supported by positive Phase 3 RINGSIDE trial data. See our latest analysis for Immunome. The FDA’s acceptance of Immunome’s NDA comes after a mixed period for the stock, with a 20.45% 1 month share price return but a 9.38% decline over three months. The 1 year total shareholder return of 110.96% points to strong longer term momentum. If this kind of...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

UroGen Pharma (URGN) Rallies On FDA Clearance As Valuation Questions Grow

UroGen Pharma (URGN) is back in focus after the FDA cleared its Investigational New Drug application for UGN-501, allowing the company to move ahead with a Phase 1 bladder cancer study. See our latest analysis for UroGen Pharma. Against this backdrop, UroGen Pharma’s share price has climbed strongly, with a 30-day share price return of 22.62% and a 90-day share price return of 78.48%, while the 1-year total shareholder return of 163.46% points to powerful momentum rather than a short-lived...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Lands Saudi Aramco Contracts For Gas, Oil And Intelligent Fracturing

Halliburton (NYSE:HAL) has secured multi-year contracts from Saudi Aramco covering unconventional gas development and onshore oil activities. The work includes deployment of Saudi Arabia’s first intelligent fracturing platform as part of a major unconventional gas project. The agreements also span a multi-year integrated oilfield program across hundreds of planned wells. Halliburton will expand local manufacturing and workforce commitments to support these projects. For investors watching...
NYSE:CUZ
NYSE:CUZOffice REITs

Cousins Properties (CUZ) Rallies Toward Fair Value, Is The Stock Fully Priced?

Cousins Properties (CUZ) has drawn fresh attention after recent trading, with the stock closing at $31.76 and showing double digit gains over both the past month and the past three months. See our latest analysis for Cousins Properties. The recent share price move in Cousins Properties builds on stronger momentum, with a 30 day share price return of 14.62% and a 90 day share price return of 31.84%, alongside a 1 year total shareholder return of 18.07%. If recent gains in Cousins Properties...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks now suggest the stock is closer to fairly priced than obviously cheap. A 139.1% total return over 5 years indicates ANI Pharmaceuticals has already rewarded patient shareholders, so fresh buyers may be weighing how much of the story is reflected in the current price. Positive topline data from the SYNCHRONICITY trial can support expectations for the branded portfolio,...
NasdaqCM:EGBN
NasdaqCM:EGBNBanks

3 U.S. Regional Bank Stocks Most Exposed To Higher Interest Rates

The Fed’s renewed hawkish tone, paired with volatile energy prices and a firm labor market, is reshaping how investors think about interest rate risk. For U.S. regional banks, tighter policy can shift the balance between what they earn on loans and what they pay on deposits, while swings in inflation expectations influence funding costs and credit demand. This article uses a focused screener of mid sized lenders to highlight 3 regional bank stocks whose business profiles could be especially...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Lands Bell Canada Ground Station And New Zealand Approval

Bell Canada has completed its first direct to device satellite ground station to support AST SpaceMobile's network in Canada. AST SpaceMobile secured new regulatory approval in New Zealand, expanding its potential service footprint. The company is preparing for the launch of additional BlueBird satellites to build out its direct to device constellation. AST SpaceMobile (NasdaqGS:ASTS) is back in focus as it adds fresh infrastructure and regulatory pieces to its direct to device puzzle. The...